Healthbeat - Your Source for Daily Health Trends and Medical News

Colin Whitaker obituary

Vet who reported the first cases in Britain of what became known as mad cow disease, or BSE, in the late 1980sColin Whitaker would happily have spent his life as a country vet, caring for farm animals

STAT+: House conservatives cave on a key demand, decreasing threat of Medicaid cuts

The budget blueprint, which passed largely on party lines, sets the stage for a bill later in the year on Trump's tax cut plan.

Nearly Half of CDC Birth Defects and Disabilities Staff Cut

(MedPage Today) -- More than 40% of the 225 scientists and public health workers at the CDC's National Center on Birth Defects and Developmental Disabilities (NCBDDD) were put on administrative leave

'Nonsensical': Califf Blasts FDA Workforce Cuts

(MedPage Today) -- In part two of this "Exit Interviews" conversation, MedPage Today editor-in-chief Jeremy Faust, MD, continues his discussion with former FDA Commissioner Robert Califf, MD.

Study: Increased Heart Risk Isn't a Given in Rheumatoid Arthritis

(MedPage Today) -- Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body mass index (BMI), use of biologic drugs for RA, and, cruc

RFK Jr. suggests some vaccines are risky or ineffective, downplays measles threat

Health secretary Robert F. Kennedy Jr.

Medicare Bleeds Billions on Pricey Bandages, and Doctors Get a Cut

Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers.

‘The Pitt’ Captures the Real Overcrowding Crisis in Emergency Rooms

From the “chairs” to the hallway medicine, the show’s depiction of an emergency medicine system that is beyond capacity rings true for medical experts.

STAT+: How job cuts at the FDA are set to slow down crucial drug reviews

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

Benefits in Myasthenia Gravis Extend to 52 Weeks With Inebilizumab

(MedPage Today) -- SAN DIEGO -- Inebilizumab (Uplizna) improved function and reduced disease severity for up to 52 weeks in generalized myasthenia gravis (gMG) patients who were acetylcholine recep

All News